Compare
Rockwell Automation, Inc vs Thermo Fisher Scientific Inc.
| Latest fiscal year | Rockwell Automation, Inc ROK | Thermo Fisher Scientific Inc. TMO |
|---|---|---|
| Year ended | 2025-09-30 | 2025-12-31 |
| Revenue | $8.34B | $44.56B |
| Revenue growth (YoY) | +0.9% | +3.9% |
| Gross margin | 48.1% | n/a |
| Operating margin | 20.4% | 17.4% |
| Net margin | 10.4% | 15.0% |
| Net income | $869.00M | $6.70B |
| EPS (Diluted) | $7.67 | $17.74 |
| Operating cash flow | $1.54B | $7.82B |
| Free cash flow | $1.36B | $6.29B |
| Cash & equivalents | $468.00M | $9.85B |
| Total assets | $11.22B | $110.34B |
| Total liabilities | n/a | n/a |
| Shareholders' equity | $3.65B | $53.41B |
| Return on year-end equity | 23.8% | 12.6% |
| Shares outstanding | 112.40M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Rockwell Automation, Inc | Thermo Fisher Scientific Inc. |
|---|---|---|
| Latest | $8.34B Ended 2025-09-30 | $44.56B Ended 2025-12-31 |
| 1 year earlier | $8.26B Ended 2024-09-30 | $42.88B Ended 2024-12-31 |
| 2 years earlier | $9.06B Ended 2023-09-30 | $42.86B Ended 2023-12-31 |
| 3 years earlier | $7.76B Ended 2022-09-30 | $44.91B Ended 2022-12-31 |
| 4 years earlier | $7.00B Ended 2021-09-30 | $39.21B Ended 2021-12-31 |